Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Health And Human Services was posted on June 26, 2023. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Safety Evaluation and Toxicology Studies and Related Services for Drug Development

Closed
75N95023R00029Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

MD

Set-Aside

NONE

Documents

3

75N95023R00029 Amendment 01

PDF, High priority: read this firstamendment
High

75N95023R00029 Amendment 02

PDF, High priority: read this firstamendment
High

RFP 75N95023R00029 and Attachments Amended 2023-06-26

PDF, High priority: read this firstamendment
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

2 updates
PhaseClosed
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Notice updated

The notice description changed.

Notice updated

Response deadline changed from Jul 10, 2023 to Jul 24, 2023. The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida
Contacts2 people available
OfficeBethesda, MD, 20892, USA
Office AddressBethesda, MD, 20892, USA
Contacts
Mark McNally Contract Specialist
Khurram Shaikh Contracting Officer

Full Description

Show more
The purpose of RFP Amendment Number 02 is to extend the proposal deadine to 03:00 PM local time on July 24, 2023; and to share the following SBCX link through which offerors are required to submit their subcontracting plans: https://osdbu.hhs.gov/subcontracting/b08bd2d7-6f7c-4317-af71-8e2302ba62b3 The purpose of RFP Amendment Number 01 is to distribute RFP questions and answers. The Therapeutic Development Branch (TDB) within the Division of Preclinical Innovation (DPI) at the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), conducts translational research on human therapeutics development by moving small molecule and biologic drug candidates forward in the drug development pipeline. Upon reaching predetermined milestones, TDB hands off clinical candidates to external partners to bring these novel therapies to patients. In addition to developing new candidate drugs, TDB seeks to advance the entire field of drug discovery and development by encouraging scientific and technological innovations aimed at improving success rates in the crucial preclinical stage of drug development. The scope of this requirement is providing safety assessment of therapeutics and diagnostics. These assessments play a pivotal role in determining and evaluating therapeutic targets; selecting and optimizing therapeutic lead candidates; and establishing first in human starting doses, dose limiting toxicities, safety/pharmacodynamic biomarkers and therapeutic indexes. The objective is to conduct toxicology studies to support the preclinical development of therapeutics and diagnostics including the submission of regulatory filings. Contractors will be required to perform in vitro and in vivo safety studies for small and large molecules to support the submission of regulatory filings to the US Food and Drug Administration (FDA) or other regulatory bodies, such as Investigational New Drug (IND) applications, New Drug Applications (NDA) and Biologics License Applications (BLA). In addition, in vitro tests and in vivo exploratory studies will be carried out to aid therapeutic target evaluation, lead optimization, and compound selection processes on a case-by-case basis. Therapeutic modalities may include new and repurposed chemical entities and biological products (e.g., monoclonal antibodies, enzymes, gene vectors, etc.). Offerors' questions regarding this RFP must be emailed by 03:00 PM EDT, June 9, 2023, to the Contract Specialist at contact@example.gov. Qestions and answers shall be published on SAM.gov to this Notice ID as an RFP amendment.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida

Same awarding agency

NAICS: 541990
New
Federal
SMART IRB Governance, Administration, and Operations Support (GAOS)
Solicitation # 75N98026Q00287
The National Center for Translational Sciences (NCATS), under the National Institutes of Health, is seeking a partner to provide Governance, Administration, and Operations Support (GAOS) for the SMART IRB portfolio of services. The selected contractor will facilitate user administration, process and workflow improvements, content development and moderation, and requirements gathering. This support extends across three primary systems: the SMARTIRB.org website for education and content distribution, the Joinder system for institutional authorization agreements, and the Online Reliance System (ORS) for documenting study-specific IRB reliance arrangements. This is a full and open competition for commercial services conducted under FAR Part 12 and FAR Subpart 13.5, with a NAICS code of 541990. The anticipated period of performance consists of a 12-month base period starting January 1, 2027, followed by three 12-month option periods and one final 6-month option period ending June 30, 2031. Performance will take place at the contractor's facility. Award decisions will be based on the most advantageous offer, evaluated against management approach and technical capabilities, personnel qualifications, and organizational experience. Key deliverables include monthly status reports, quarterly metrics and analysis, and a final closeout report. All invoices must be processed electronically through the Department of Treasury Invoice Processing Platform.
All Other Professional, Scientific, and Technical Services

POSTED

1 day ago

DEADLINE

in 15 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS